Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy and relapse rate of low dose, short
duration treatment with tamoxifen in benign breast disease amenable to hormonal therapy with
respect to etiology and estrogen receptor status and to realize its side-effects and cost of
therapy.
To do a comparative analysis of the results with evening primrose oil which is one of the
first line management in benign breast disease.